Celgene Corporation

Available to platforms

Celgene Corporation (Ticker: CELG) was a global biopharmaceutical company specializing in the development and commercialization of therapies for cancer and inflammatory diseases. Its flagship products included Revlimid, a treatment for multiple myeloma, and Otezla, a therapy for psoriasis and psoriatic arthritis. In 2019, Celgene was acquired by Bristol Myers Squibb in a landmark $74 billion deal, expanding Bristol Myers Squibb’s oncology and immunology portfolio.

Celgene Corporation - CELG stocks live chart

Analyze price movements of Celgene Corporation online with R StocksTrader stock charts. You don't need to refresh chart as the quotes are updated automatically. View the current and previous CELG quotes, get all necessary information for adding Celgene Corporation to your investment portfolio.

You can invest in Celgene Corporation and real stocks and CFDs on stocks of other American and European companies in R StocksTrader. Stocks, Indices, Metals: 12,000 assets in total are available for trading in the web terminal. Explore price movements of popular assets, like Celgene Corporation, in our "Charts" section and expand your trading opportunities by investing in new instruments.

Risk Warning: past performance of CELG does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Celgene Corporation (CELG).

You can trade Celgene Corporation (CELG) on the R StocksTrader platform.

You can trade online Celgene Corporation (CELG) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts